Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Doxycycline in Relapsed NHL

NCT02086591 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT02086591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02086591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Doxycycline in Relapsed NHL
Lead sponsor
University of Rochester
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2014
Completion date
November 30, 2015
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult diffuse large b-cell lymphoma, chronic lymphocytic leukemia (cll), lymphoma, follicular, malignant lymphoma - lymphoplasmacytic, mantle cell lymphoma recurrent, marginal zone b-cell lymphoma, small lymphocytic lymphoma, t-cell lymphoma, waldenstrom macroglobulinemia